Evidence map›Paper›PMID 41238361›Full record

ArticleBMJ open2025

Associations between heart failure-related quality of life and clinical parameters in patients with hypertrophic cardiomyopathy: a cross-sectional analysis of data from a multicentre Japanese registry.

Masao Saotome, Keitaro Akita, Shigetaka Kageyama, Sayumi Suzuki, Kazuto Ohno, Masamitsu Kamakura, Ryuzo Nawada, Chiei Takanaka, Yasushi Wakabayashi, Takahiro Kanda and 21 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Masao SaotomeDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Keitaro AkitaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan keitaro.akita@gmail.com.ORCID http://orcid.org/0000-0001-5395-1887
Shigetaka KageyamaDepartment of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Sayumi SuzukiDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kazuto OhnoDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Masamitsu KamakuraDepartment of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Ryuzo NawadaDepartment of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Chiei TakanakaTakanaka Clinic, Hamamatsu, Japan.
Yasushi WakabayashiDepartment of Cardiology, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Takahiro KandaDepartment of Cardiology, Hamamatsu Red Cross Hospital, Hamamatsu, Japan.
Kei TawaraharaDepartment of Cardiology, Hamamatsu Red Cross Hospital, Hamamatsu, Japan.
Masahiro MutoDepartment of Cardiology, Hamamatsu Medical Center, Hamamatsu, Japan.
Masaki MatsunagaDepartment of Cardiology, Iwata City Hospital, Iwata, Japan.
Satoru SuwaDepartment of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
Yasuyo TakeuchiDepartment of Cardiovascular Medicine, Shizuoka General Hospital, Shizuoka, Japan.
Hiroki SakamotoDepartment of Cardiovascular Medicine, Shizuoka General Hospital, Shizuoka, Japan.
Hideki SaitoDepartment of Cardiology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Kazusa HayashiDepartment of Internal Medicine, JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu, Japan.
Nobuyuki WakaharaDepartment of Cardiology, Fujinomiya City General Hospital, Fujinomiya, Japan.
Kyoko UnnoDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Takenori IkomaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Ryota SatoDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Keisuke IguchiDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Terumori SatohDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Makoto SanoDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Atsushi SakamotoDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kenichiro SuwaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.ORCID http://orcid.org/0000-0001-6934-7932
Yoshihisa NaruseDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.ORCID http://orcid.org/0000-0001-9630-951X
Hayato OhtaniDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Yuichiro MaekawaDivision of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Searching for Atrial Fibrillation and Early Recruitment of Heart Failure in HCM (SAFER-HCM) Registry Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the relationship between a quality of life (QOL) score and clinical parameters in patients with hypertrophic cardiomyopathy (HCM).

designA multicentre cross-sectional study.

settingWe analysed data from the Searching for Atrial Fibrillation and Early Recruitment of Heart Failure in HCM registry, collected between 2018 and 2023.

participantsPatients with HCM (n=499) aged ≥18 years from 12 institutions (Shizuoka Prefecture, Japan) were consecutively enrolled. OUTCOME MEASURES: Clinical parameters, along with data from a short form of the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), were collected. The association between each clinical parameter and the KCCQ-12 score was analysed. Clinical parameters with a significant univariable association (p<0.05) were used in a multiple regression model to investigate independent clinical parameters associated with the KCCQ-12 score. The coefficients and relative importance of each parameter included in the multiple regression model were also evaluated.

resultsIn the univariable analysis, KCCQ-12 scores exhibited significant associations with 21 clinical parameters, including sex, left ventricular morphology and the Pittsburgh Sleep Quality Index (PSQI). The multiple regression model with 12 parameters that had a significant univariable association exhibited an adjusted R

conclusionsIn patients with HCM, we investigated the association between the KCCQ-12 score and various clinical parameters. PSQI, as well as known heart failure-related clinical parameters, was significantly associated with the KCCQ-12 score. Visualising the associations of various clinical parameters with the KCCQ-12 score will help physicians to consider factors linked to the decline in QOL in patients with HCM.

Indexed as

Cardiomyopathy, HypertrophicHeart FailureQuality of LifeAdultAgedCross-Sectional StudiesEast Asian PeopleFemaleHumansJapanMaleMiddle AgedRegistriesSurveys and Questionnairescardiomyopathyheart failurequality of life

Identifiers

PMID41238361
PMCPMC12625877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.